透過您的圖書館登入
IP:18.222.162.216
  • 學位論文

泌乳素之訊息傳遞於不朽化山羊乳腺上皮細胞株中之探討

The prolactin signal transduction cascade in immortal caprine mammary epithelial cell lines

指導教授 : 朱有田
共同指導教授 : 姜延年

摘要


成熟雌性哺乳動物其乳腺發育分為四個時期:處女期、懷孕期、泌乳期及離乳期。其中由腦垂腺所分泌之泌乳素 (prolactin, PRL) 於乳腺上皮細胞之生長、分化及泌乳扮演重要的角色。於泌乳時,泌乳素能透過結合於泌乳素接受體 (prolactin receptor, PRLR) 之酪胺酸激脢Jak-2磷酸化泌乳素接受體,然後泌乳素接受體磷酸化主要之訊號傳遞分子 (signal transducer and activator of transcription 5a, STAT5a),磷酸化之STAT5a會從細胞質轉移至細胞核,進而調控 b-酪蛋白啟動子之活性。此外,在Caveolin-1 (Cav-1) 的研究中亦發現,Cav-1剔除的小鼠其乳腺管及泡狀構造有提早成熟、提前泌乳與高度磷酸化STAT5a的現象,並且Cav-1認定為具有負調控Jak-2/STAT5a訊息傳遞之功能。另外在小鼠乳腺中,亦了解泌乳素能透過Ras-MAP Kinase訊息傳遞之路徑負調控Cav-1蛋白之表現。 經比對山羊與人類、山羊與小鼠之Cav-1啟動子序列,其相似度分別為74%、67%。亦比對山羊與人類、山羊與小鼠 b-酪蛋白基因轉錄起始點上游1683個核酸序列,其相似度分別為46%、49%。由於各物種間序列相似度上的差異,因此本研究之目的想探討山羊Cav-1於不朽化山羊乳腺上皮細胞 (caprine mammary epithelial cells, CMEC) 中之功能是否相似於人類及小鼠。 首先,透過puromycin的篩選,建立穩定表現人類泌乳素接受體 (human prolactin receptor, hPRLR) 之CMEC (CMEC/hPRLR)。為測定山羊 b-酪蛋白啟動子之活性,構築由山羊 b-酪蛋白啟動子 (-1683 - -1) 驅動表現螢火蟲冷光素之質體,並且為矯正轉型效率,亦構築由thymidine kinase (TK) 啟動子驅動表現珊瑚蟲冷光素之質體,並透過將上述二質體共同轉染入CMEC/hPRLR,再經泌乳素刺激,以建立由泌乳素誘導山羊 b-酪蛋白啟動子之系統。經由此系統,山羊 b-酪蛋白啟動子經泌乳素刺激後能提高36.1倍之活性。為了解泌乳素處理濃度對內源性山羊Cav-1表現之影響,以6種不同最終濃度 (濃度從0至15 ug/mL) 之泌乳素處理CMEC/hPRLR,並且在三個時間點 (處理後24、48及72小時) 抽取細胞總蛋白質,經西方吸漬法分析,內源性山羊Cav-1表現量於泌乳素處理後48及72小時,隨處理濃度之增加逐漸減少。接著為探討山羊Cav-1是否會減少泌乳素訊息傳遞誘導之STAT5a磷酸化,將山羊Cav-1質體與山羊STAT5a質體共同轉染入CMEC/hPRLR中,並以泌乳素刺激,經西方吸漬法分析,山羊STAT5a磷酸化程度明顯下降,此外轉染綠螢光蛋白 (EGFP) 之負控制組,並未影響山羊STAT5a的磷酸化。最後為探討山羊Cav-1是否透過降低山羊STAT5a磷酸化,進而降低山羊 b-酪蛋白啟動子之活性,因此於泌乳素誘導山羊 b-酪蛋白啟動子之系統中額外轉染山羊Cav-1,亦觀察到山羊 b-酪蛋白啟動子活性之降低。 由以上結果可知,CMEC/hPRLR經泌乳素之處理能減少內源性山羊Cav-1之表現,若外源性提高表現山羊Cav-1則會降低山羊STAT5a之磷酸化及降低山羊 b-酪蛋白啟動子之活性。因此,泌乳素處理CMEC/hPRLR時,其內源性山羊Cav-1表現降低及STAT5a磷酸化程度提高,對於促進不朽化山羊乳腺上皮細胞活化山羊 b-酪蛋白啟動子為重要之調控。

並列摘要


Development of the adult female mammary gland encounters four distinct stages: virgin, pregnancy, lactation, and involution. During mammary gland development, prolactin (PRL), a pituitary hormone, mediates mammary epithelial cell growth, differentiation and lactation. The act of prolactin in regulating the activity of b-casein promoter via the activation of prolactin tyrosine kinase associated receptor, and its associated protein kinase, Jak-2. Signal transducer and activator of transcription 5a (STAT5a) is the key signaling molecule transfers the prolactin signal from Jak-2 to b-casein promoter. Once STAT5a phosphorylated by Jak-2, STAT5a translocates from the cytoplasm to the nucleus, and activates b-casein promoter during lactation. Besides, based on the study of Caveolin-1 (Cav-1), its null mice accelerated the development of the labuloalveolar compartment, premature milk production, and hyperphosphorylation of STAT5a. In addition, Cav-1 is identified as a negative regulator of Jak-2/STAT5a signaling pathway. Prolactin down-regulates Cav-1 expression via Ras-MAP Kinase pathway also been identified in mouse mammary epithelial cells. The Cav-1 promoter sequence identity between goat versus human and goat versus mouse was 74% and 67%, respectively. The comparison of 1683 nucleotides upstream the transcription start site of b-casein gene between goat versus human and goat versus mouse the sequence similarity is 46% and 49%, respectively. Because diversity among those sequences, the goal in present study is to understand whether the function of goat Cav-1 in caprine mammary epithelial cell (CMEC) is similar to that in mouse and human. First of all, stable expression of PRL receptor CMEC cells (CMEC/PRLR) lines were established via puromycin selection. In order to measure the b-casein promoter activity, a plasmid possessed goat b-casein promoter (-1683 – -1) drove firefly luciferase (Fluc) reporter protein was constructed. For equivalent the transfection efficiency, another plasmid possessed TK (thymidine kinase) promoter drove the renilla luciferase (Rluc) reporter protein also been constructed. A system that prolactin mediated b-casein promoter in CMEC/PRLR cells was established by co-expression of b-casein promoter Fluc plasmid and TK promoter Rluc plasmid in the CMEC/PRLR cells in response to the stimulation of PRL. The activity of goat b-casein promoter activity was enhanced 36.1 fold after PRL treatment. To understand the dosage effect of PRL to the endogenous Cav-1 expression, 6 final PRL concentrations (range from 0 to 15 ug/ml) were used to treat the CMEC/PRLR cells, then the cell proteins were harvested at 3 time courses (24, 48, 72 hr post-treatment). The results show that endogenous Cav-1 down-regulated in response to PRL treatment at 48, and 72 hr and dose dependent. To study whether goat Cav-1 could down-regulate the activity (phosphorylation) of STAT5a via PRL signal cascade, the phsphorylayion state of STAT5a were determined with or without exogenous goat Cav-1 protein expression in CMEC/PRLR cells after PRL stimulation. The phosphorylation of STAT5a was decreased after PRL stimulation, furthermore expression of the control protein EGFP (Enhanced Green Fluorescent Proteins) did not alter STAT5a phosphorylation. Finally, to study whether goat Cav-1 could down-regulate the b-casein promoter activity by down-regulate the phosphorylation of STAT5a. We transient transfect gCav-1 in the PRL induce b-casein promoter system. The gCav-1 also down-regulate the b-casein promoter activity. In conclusion, these results showed that PRL down-regulated the endogenous Cav-1 expression, and elevated expression of exogenous Cav-1 decreased the phosphorylation of STAT5a proteins and b-casein promoter activity. Therefore, PRL down-regulated endogenous Cav-1 expression and up-regulated STAT5a phosphorylation is important for improving b-casein promoter activity in CMEC.

參考文獻


Biswas, R. and B. K. Vonderhaar. 1987. Role of serum in the prolactin responsiveness of MCF-7 human breast cancer cells in long-term tissue culture. Cancer Res. 47: 3509-3514.
Chilton, B. S. and A. Hewetson. 2005. Prolactin and growth hormone signaling. Curr. Top. Dev. Biol. 68: 1-23.
Chomczynski, P., P. Qasba, and Y. J. Topper. 1984. Essential role of insulin in transcription of the rat 25,000 molecular weight casein gene. Science 226: 1326-1328.
Cohen, A. W., R. Hnasko, W. Schubert, and M. P. Lisanti. 2004. Role of caveolae and caveolins in health and disease. Physiol. Rev. 84: 1341-1379.
Couet, J., S. Li, T. Okamoto, T. Ikezu, and M. P. Lisanti. 1997. Identification of peptide and protein ligands for the caveolin-scaffolding domain. Implications for the interaction of caveolin with caveolae-associated proteins. J. Biol. Chem. 272: 6525-6533.

延伸閱讀